Pilot study evaluates bacterial signatures linked to candida overgrowth in patients, suggesting new interactions.
Despite overall stability of the oral microbiota during therapy, specific bacterial signatures were associated with subsequent Candida overgrowth. These findings suggest that cross-kingdom interactions may influence susceptibility to corticosteroid-associated candidiasis and warrant validation in larger cohorts.
No takes yet. Share an insight, caveat, or question.
Dormiente et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: